EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen Shewanella algae

Celia García-Rivera, Juan J Roda-Garcia, Juan Carlos Rodríguez, Carmen Molina-Pardines, Iryna Tyshkovska, Jose M Haro-Moreno iD, Antonio Martínez-Murcia, Maria Paz Ventero iD, Mario López-Pérez iD

Antimicrobial Agents and Chemotherapy · 06.05.2026 · 70 (5)

DOI: 10.1128/aac.01891-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 06.05.2026. Verfasst von Celia García-Rivera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain. Hauptthemen laut MEDLINE: Shewanella, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Competitividad, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of antimicrobial resistance in environmental bacteria threatens therapeutic efficacy in clinical settings. Shewanella algae , historically regarded as a marine saprophyte, is increasingly recognized as an emerging opportunistic pathogen. In this study, we analyzed 86 S. algae isolates from Spain (19 clinical and 67 environmental) and integrated them with 178 publicly available genomes to explore antimicrobial susceptibility patterns and genomic diversity. Penicillins and fosfomycin consistently showed poor activity, whereas piperacillin/tazobactam, third- and fourth-generation cephalosporins, aminoglycosides, ciprofloxacin, trimethoprim–sulfamethoxazole and several novel β-lactam–inhibitor combinations exhibited low MIC distributions. Recently introduced agents, including ceftazidime/avibactam, ceftolozane/tazobactam, and cefiderocol, also demonstrated strong in vitro activity. Carbapenems displayed an unusual intraclass pattern, with imipenem showing markedly higher MICs than meropenem and ertapenem. When interpreted using CLSI’s “Other Non-Enterobacterales” criteria, clinical and environmental isolates exhibited largely overlapping susceptibility profiles, highlighting the potential role of environmental strains as reservoirs of resistance-related traits. Genomic profiling revealed a conserved intrinsic resistome (OXA-type β-lactamases, qnrA variants, ugd , and efflux regulators) together with horizontally acquired determinants. A 29 kb genomic island carrying multiple resistance genes was identified in a clinical isolate, with homologous structures detected in Vibrio and Proteus , suggesting interspecies transfer. Furthermore, plasmids harboring class 1 integrons (mobile integrons) were widespread, shared with Enterobacterales and Vibrionaceae across clinical and environmental settings. Overall, these findings highlight S. algae as both a clinically relevant pathogen and a reservoir of mobile AMR determinants and underscore the urgent need for species-specific antimicrobial susceptibility interpretive criteria to improve clinical decision-making for this emerging pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ShewanellaAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsHumansIntegronsDrug Resistance, BacterialCefiderocolPlasmids

Stichwörter der Autor:innen

One HealthShewanella algaeantibiotic resistanceantimicrobial resistancemobile genetic elementsmobile integronpathogen emergence

Substanzen

Anti-Bacterial AgentsCefiderocol

Autor:innen und Institutionen

  • Microbiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
  • Microbial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.
  • Genetic PCR Solutions, Orihuela, Spain.

ORCID-Profile: Jose M Haro-Moreno, Maria Paz Ventero, Mario López-Pérez

Förderung

  • Ministerio de Economía y Competitividad
  • Ministerio de Ciencia e Innovación

Zitieren

APA

García-Rivera, C., Roda-Garcia, J. J., Rodríguez, J. C., Molina-Pardines, C., Tyshkovska, I., Haro-Moreno, J. M., Martínez-Murcia, A., Ventero, M. P., & López-Pérez, M. (2026). Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen Shewanella algae. Antimicrobial Agents and Chemotherapy, 70(5). https://doi.org/10.1128/aac.01891-25

Vancouver

García-Rivera C, Roda-Garcia JJ, Rodríguez JC, Molina-Pardines C, Tyshkovska I, Haro-Moreno JM, et al. Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen Shewanella algae. Antimicrobial Agents and Chemotherapy. 2026;70(5). doi:10.1128/aac.01891-25

BibTeX
@article{GarcaRivera2026,
  author = {García-Rivera, Celia and Roda-Garcia, Juan J and Rodríguez, Juan Carlos and Molina-Pardines, Carmen and Tyshkovska, Iryna and Haro-Moreno, Jose M and Martínez-Murcia, Antonio and Ventero, Maria Paz and López-Pérez, Mario},
  title = {Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen Shewanella algae},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {5},
  doi = {10.1128/aac.01891-25}
}
Kostenlos starten →